ProQR Therapeutics' short term liquidity and more cash than ...
ProQR Therapeutics' short term liquidity and more cash than debt suggest it can manage its debt safely. Its 38% revenue growth is a positive sign, indicating potential for further strong growth.
![](https://pubimg-10000538.picsh.myqcloud.com/20220509000002939036dcfc641.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment